About 1 result found for searched term "Canakinumab" (0.138 seconds)
Cat.No. | Name | Target |
---|---|---|
M25286 | Canakinumab | IL Receptor/Related |
Ilaris ACZ 885 | ||
Canakinumab (ACZ885) is a recombinant human anti-IL-1β monoclonal antibody. Canakinumab shows IC50 values of 43.6 and 40.8 pM for human and marmoset IL-1β, respectively. The mode of action of canakinumab is based on the neutralization of IL-1β signaling, resulting in suppression of inflammation related to disorders of autoimmune origin. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.